Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen C Cheng

Showing results (411-420 of 437) with videos related to

Pageof 44
Sort By:
Nature Communications|May 12, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patientsThi H O Nguyen, Marios Koutsakos, Carolien E van de Sandt, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Nature Communications|November 24, 2025
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signaturesAira F Cabug, Jeremy Chase Crawford, Hayley A McQuilten, et al.
MMWR. Morbidity and Mortality Weekly Report|September 25, 2025
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025Savanah Russ, Francisco Nogareda, Annette K Regan, et al.
Nature Immunology|February 20, 2019
Human CD8<sup>+</sup> T cell cross-reactivity across influenza A, B and C virusesMarios Koutsakos, Patricia T Illing, Thi H O Nguyen, et al.
Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Nature Communications|May 19, 2021
CD8<sup>+</sup> T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorphLuca Hensen, Patricia T Illing, E Bridie Clemens, et al.
Immunity|May 5, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.
JAMA|February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical TrialSteven Y C Tong, David C Lye, Dafna Yahav, et al.
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
Pageof 44

Showing results (411-420 of 437) with videos related to

Sort By:
Pageof 44
Nature Communications|May 12, 2021
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patientsThi H O Nguyen, Marios Koutsakos, Carolien E van de Sandt, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
Nature Communications|November 24, 2025
High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signaturesAira F Cabug, Jeremy Chase Crawford, Hayley A McQuilten, et al.
MMWR. Morbidity and Mortality Weekly Report|September 25, 2025
Interim Effectiveness Estimates of 2025 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Outpatient and Hospitalized Illness - Eight Southern Hemisphere Countries, March-September 2025Savanah Russ, Francisco Nogareda, Annette K Regan, et al.
Nature Immunology|February 20, 2019
Human CD8<sup>+</sup> T cell cross-reactivity across influenza A, B and C virusesMarios Koutsakos, Patricia T Illing, Thi H O Nguyen, et al.
Ebiomedicine|December 6, 2021
A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2Thomas S Fulford, Huy Van, Nicholas A Gherardin, et al.
Nature Communications|May 19, 2021
CD8<sup>+</sup> T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorphLuca Hensen, Patricia T Illing, E Bridie Clemens, et al.
Immunity|May 5, 2021
CD8<sup>+</sup> T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuityThi H O Nguyen, Louise C Rowntree, Jan Petersen, et al.
JAMA|February 12, 2020
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical TrialSteven Y C Tong, David C Lye, Dafna Yahav, et al.
Nature Immunology|May 29, 2023
Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbiditiesWuji Zhang, Lukasz Kedzierski, Brendon Y Chua, et al.
Pageof 44